Impact of surgery-radiation interval on locoregional outcome in patients receiving neo-adjuvant therapy and mastectomy

Shiv Desai, Judith Hurley, Cristiane Takita, Isildinha Reis, Wei Zhao, Steven Rodgers, Jean L. Wright

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Delays in the initiation of radiation are increasingly common for medically underserved patients. We evaluated the impact of delay in initiation of postmastectomy radiation (PMRT) in breast cancer patients treated with neo-adjuvant therapy (NAT) in a cohort of medically underserved patients with multiple barriers to timely care. We retrospectively reviewed medical records of 248 consecutively treated patients. Clinical stage was 34.4% II, 65.6% III. The median interval from surgery to PMRT was 11.9 weeks; 22.2% started PMRT within 8 weeks of surgery, 52% within 12 weeks, and 67.3% within 16 weeks. The cumulative 5-year incidence of locoregional recurrence (LRR) was 5.8% (95% CI: 3.2-9.7). There was no significant difference in locoregional outcome among patients starting PMRT within 8 weeks versus >8 weeks (p = 0.634), ≤12 versus >12 weeks (p = 0.332), or ≤16 versus >16 weeks (p = 0.549) after surgery. Although timely initiation of PMRT remains a priority, the locoregional control benefit of PMRT appears to be maintained up to at least 16 weeks, and in those without early locoregional recurrence, PMRT should be offered despite such a delay.

Original languageEnglish
Pages (from-to)427-430
Number of pages4
JournalBreast Journal
Volume19
Issue number4
DOIs
StatePublished - Jul 1 2013

Fingerprint

Mastectomy
Radiation
Vulnerable Populations
Therapeutics
Recurrence
Medical Records
Breast Neoplasms
Incidence

Keywords

  • breast cancer
  • intervals
  • locoregional outcome
  • postmastectomy
  • radiation

ASJC Scopus subject areas

  • Internal Medicine
  • Oncology
  • Surgery

Cite this

Impact of surgery-radiation interval on locoregional outcome in patients receiving neo-adjuvant therapy and mastectomy. / Desai, Shiv; Hurley, Judith; Takita, Cristiane; Reis, Isildinha; Zhao, Wei; Rodgers, Steven; Wright, Jean L.

In: Breast Journal, Vol. 19, No. 4, 01.07.2013, p. 427-430.

Research output: Contribution to journalArticle

@article{528a8747b86948b19644e0cf5c46709e,
title = "Impact of surgery-radiation interval on locoregional outcome in patients receiving neo-adjuvant therapy and mastectomy",
abstract = "Delays in the initiation of radiation are increasingly common for medically underserved patients. We evaluated the impact of delay in initiation of postmastectomy radiation (PMRT) in breast cancer patients treated with neo-adjuvant therapy (NAT) in a cohort of medically underserved patients with multiple barriers to timely care. We retrospectively reviewed medical records of 248 consecutively treated patients. Clinical stage was 34.4{\%} II, 65.6{\%} III. The median interval from surgery to PMRT was 11.9 weeks; 22.2{\%} started PMRT within 8 weeks of surgery, 52{\%} within 12 weeks, and 67.3{\%} within 16 weeks. The cumulative 5-year incidence of locoregional recurrence (LRR) was 5.8{\%} (95{\%} CI: 3.2-9.7). There was no significant difference in locoregional outcome among patients starting PMRT within 8 weeks versus >8 weeks (p = 0.634), ≤12 versus >12 weeks (p = 0.332), or ≤16 versus >16 weeks (p = 0.549) after surgery. Although timely initiation of PMRT remains a priority, the locoregional control benefit of PMRT appears to be maintained up to at least 16 weeks, and in those without early locoregional recurrence, PMRT should be offered despite such a delay.",
keywords = "breast cancer, intervals, locoregional outcome, postmastectomy, radiation",
author = "Shiv Desai and Judith Hurley and Cristiane Takita and Isildinha Reis and Wei Zhao and Steven Rodgers and Wright, {Jean L.}",
year = "2013",
month = "7",
day = "1",
doi = "10.1111/tbj.12140",
language = "English",
volume = "19",
pages = "427--430",
journal = "Breast Journal",
issn = "1075-122X",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Impact of surgery-radiation interval on locoregional outcome in patients receiving neo-adjuvant therapy and mastectomy

AU - Desai, Shiv

AU - Hurley, Judith

AU - Takita, Cristiane

AU - Reis, Isildinha

AU - Zhao, Wei

AU - Rodgers, Steven

AU - Wright, Jean L.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Delays in the initiation of radiation are increasingly common for medically underserved patients. We evaluated the impact of delay in initiation of postmastectomy radiation (PMRT) in breast cancer patients treated with neo-adjuvant therapy (NAT) in a cohort of medically underserved patients with multiple barriers to timely care. We retrospectively reviewed medical records of 248 consecutively treated patients. Clinical stage was 34.4% II, 65.6% III. The median interval from surgery to PMRT was 11.9 weeks; 22.2% started PMRT within 8 weeks of surgery, 52% within 12 weeks, and 67.3% within 16 weeks. The cumulative 5-year incidence of locoregional recurrence (LRR) was 5.8% (95% CI: 3.2-9.7). There was no significant difference in locoregional outcome among patients starting PMRT within 8 weeks versus >8 weeks (p = 0.634), ≤12 versus >12 weeks (p = 0.332), or ≤16 versus >16 weeks (p = 0.549) after surgery. Although timely initiation of PMRT remains a priority, the locoregional control benefit of PMRT appears to be maintained up to at least 16 weeks, and in those without early locoregional recurrence, PMRT should be offered despite such a delay.

AB - Delays in the initiation of radiation are increasingly common for medically underserved patients. We evaluated the impact of delay in initiation of postmastectomy radiation (PMRT) in breast cancer patients treated with neo-adjuvant therapy (NAT) in a cohort of medically underserved patients with multiple barriers to timely care. We retrospectively reviewed medical records of 248 consecutively treated patients. Clinical stage was 34.4% II, 65.6% III. The median interval from surgery to PMRT was 11.9 weeks; 22.2% started PMRT within 8 weeks of surgery, 52% within 12 weeks, and 67.3% within 16 weeks. The cumulative 5-year incidence of locoregional recurrence (LRR) was 5.8% (95% CI: 3.2-9.7). There was no significant difference in locoregional outcome among patients starting PMRT within 8 weeks versus >8 weeks (p = 0.634), ≤12 versus >12 weeks (p = 0.332), or ≤16 versus >16 weeks (p = 0.549) after surgery. Although timely initiation of PMRT remains a priority, the locoregional control benefit of PMRT appears to be maintained up to at least 16 weeks, and in those without early locoregional recurrence, PMRT should be offered despite such a delay.

KW - breast cancer

KW - intervals

KW - locoregional outcome

KW - postmastectomy

KW - radiation

UR - http://www.scopus.com/inward/record.url?scp=84879783467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879783467&partnerID=8YFLogxK

U2 - 10.1111/tbj.12140

DO - 10.1111/tbj.12140

M3 - Article

C2 - 23750652

AN - SCOPUS:84879783467

VL - 19

SP - 427

EP - 430

JO - Breast Journal

JF - Breast Journal

SN - 1075-122X

IS - 4

ER -